SLDB
Solid Biosciences Inc.
$5.17
+$0.05(+0.98%)
63
Overall
--
Value
63
Tech
--
Quality
Market Cap
$421.27M
Volume
624.90K
52W Range
$2.41 - $8.01
Target Price
$15.58
Order:
Income Statement
| Metric | Trend | Chart | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Total Revenue | -- | -- | -- | $13.6M | $8.1M | $1.1M | $963.0K | ||
| Total Revenue | -- | -- | -- | $13.6M | $8.1M | $1.1M | $963.0K | ||
| COST OF GOODS SOLD | |||||||||
| Cost of Revenue | -- | -- | -- | $777.0K | $1.5M | -- | -- | ||
| GROSS PROFIT | |||||||||
| Gross Profit | -- | -- | -- | $13.6M | $8.1M | $1.1M | $963.0K | ||
| OPERATING EXPENSES | |||||||||
| Operating Expenses | $75.7M | $119.3M | $88.4M | $85.9M | $107.4M | $104.3M | $129.7M | ||
| Research & Development | $58.0M | $94.7M | $64.9M | $58.7M | $78.4M | $76.6M | $96.4M | ||
| Research Expense | $58.0M | $94.7M | $64.9M | $58.7M | $78.4M | $76.6M | $96.4M | ||
| Selling, General & Administrative | $17.7M | $24.6M | $21.6M | $27.1M | $28.9M | $27.8M | $33.3M | ||
| General & Administrative Expenses | $17.7M | $24.6M | $21.6M | $27.1M | $28.9M | $27.8M | $33.3M | ||
| Salaries & Wages | $-6.0M | $14.2M | $11.6M | -- | -- | $7.6M | $10.5M | ||
| Depreciation & Amortization | $-1.6M | $2.8M | $3.9M | $3.0M | $2.4M | $2.6M | $2.5M | ||
| Depreciation & Amortization | $-1.6M | $2.8M | $3.9M | $3.0M | $2.4M | $2.6M | $2.5M | ||
| Amortization | -- | -- | -- | -- | -- | $476.0K | $441.0K | ||
| Other Operating Expenses | $-75.7M | $2.5M | $2.6M | $2.6M | $3.9M | $5.3M | $5.0M | ||
| OPERATING INCOME | |||||||||
| Operating income | $-75.7M | $-119.3M | $-88.4M | $-72.3M | $-106.5M | $-104.3M | $-129.7M | ||
| EBITDA | $-73.3M | $-114.7M | $-82.5M | $-69.3M | $-96.9M | $-93.0M | $-121.9M | ||
| NON-OPERATING ITEMS | |||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | -- | -- | $440.0K | $340.0K | ||
| Intinc | $619.0K | $1.6M | $115.0K | $64.0K | $2.6M | $7.6M | $9.5M | ||
| Net Non-Operating Interest Income/Expense | $619.0K | $1.6M | $115.0K | $64.0K | $2.6M | $7.6M | $9.5M | ||
| Gain on Sale of Securities | -- | -- | -- | -- | -- | -- | $-4.8M | ||
| Other Income/Expense | $-270.0K | $-515.0K | $-1.0K | $-2.0K | $10.7M | $-1.1M | $4.1M | ||
| Other Special Charges | $270.0K | $515.0K | $1.0K | $2.0K | $17.9M | $1.1M | $652.0K | ||
| SPECIAL ITEMS | |||||||||
| Restructring And Mn A Income | -- | -- | $1.9M | -- | $7.2M | $-63.0K | -- | ||
| Special Income Charges | -- | -- | $-1.9M | -- | $-7.2M | $63.0K | -- | ||
| Other Impairment Of Capital Assets | -- | -- | -- | -- | -- | $400.0K | -- | ||
| PRE-TAX INCOME | |||||||||
| EBIT | $-74.8M | $-117.2M | $-86.5M | $-72.3M | $-99.3M | $-95.6M | $-124.4M | ||
| Pre-Tax Income | $-74.8M | $-117.2M | $-88.3M | $-72.2M | $-86.0M | $-95.6M | $-124.7M | ||
| NET INCOME | |||||||||
| Net Income | $-74.8M | $-117.2M | $-88.3M | $-72.2M | $-86.0M | $-96.0M | $-124.7M | ||
| Net Income (Continuing Operations) | $-74.8M | $-117.2M | $-88.3M | $-72.2M | $-86.0M | $-96.0M | $-124.7M | ||
| Net Income (Discontinued Operations) | $-74.8M | $-117.2M | $-88.3M | $-72.2M | $-86.0M | $-96.0M | $-124.7M | ||
| Net Income (Common Stockholders) | $-74.8M | $-117.2M | $-88.3M | $-72.2M | $-86.0M | $-96.0M | $-124.7M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | $-123.1M | ||
| TOTALS | |||||||||
| Total Expenses | $75.7M | $119.3M | $88.4M | $86.7M | $107.4M | $104.3M | $129.7M | ||
| SHARE & EPS DATA | |||||||||
| Average Shares Outstanding | $2.2M | $2.7M | $3.5M | $7.1M | $8.5M | $19.9M | $40.8M | ||
| Average Shares Outstanding (Diluted) | $2.2M | $2.7M | $3.5M | $7.1M | $8.5M | $19.9M | $40.8M | ||
| Shares Outstanding | $2.4M | $3.1M | $5.7M | $7.4M | $19.6M | $37.8M | $77.5M | ||
| Basic EPS | -- | $-43.65 | $-25.5 | -- | $-10.1 | $-4.83 | $-3.06 | ||
| Basic EPS (Continuing Operations) | -- | $-43.65 | $-25.5 | -- | $-10.1 | $-4.83 | $-3.06 | ||
| Diluted EPS | $-33.75 | $-43.65 | $-25.5 | $-10.2 | $-10.1 | $-4.83 | $-3.06 | ||
| Diluted EPS (Continuing Operations) | $-33.75 | -- | -- | $-10.2 | $-10.1 | $-4.83 | $-3.06 | ||
| OTHER METRICS | |||||||||
| Minority Interests | -- | $80.0M | $132.1M | -- | $211.7M | -- | -- | ||
| Other Gand A | $17.7M | $24.6M | $21.6M | $27.1M | $28.9M | $27.8M | $33.3M | ||
| Restruct | -- | -- | $1.9M | -- | $7.2M | $-63.0K | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SLDB | $5.17 | +1.0% | 624.90K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |